These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 26195821

  • 1. Orphan Nuclear Receptor Nur77 Inhibits Cardiac Hypertrophic Response to Beta-Adrenergic Stimulation.
    Yan G, Zhu N, Huang S, Yi B, Shang X, Chen M, Wang N, Zhang GX, Talarico JA, Tilley DG, Gao E, Sun J.
    Mol Cell Biol; 2015 Oct; 35(19):3312-23. PubMed ID: 26195821
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional up-regulation of relaxin-3 by Nur77 attenuates β-adrenergic agonist-induced apoptosis in cardiomyocytes.
    You X, Guo ZF, Cheng F, Yi B, Yang F, Liu X, Zhu N, Zhao X, Yan G, Ma XL, Sun J.
    J Biol Chem; 2018 Sep 07; 293(36):14001-14011. PubMed ID: 30006349
    [Abstract] [Full Text] [Related]

  • 3. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H, Nazmy M, Kajimoto K, Yehia G, Molina CA, Sadoshima J.
    Circ Res; 2003 Jul 11; 93(1):12-22. PubMed ID: 12791704
    [Abstract] [Full Text] [Related]

  • 4. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H, Gao S, Ye J, Feng X, Cai Y, Liu Z, Lu J, Li Q, Huang X, Chen S, Liu P.
    Mol Cell Endocrinol; 2014 Feb 15; 382(2):998-1006. PubMed ID: 24291639
    [Abstract] [Full Text] [Related]

  • 5. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H, Jia G, Liu X, Liu Z, Wang H.
    Environ Toxicol Pharmacol; 2014 Jul 15; 38(1):263-71. PubMed ID: 24975447
    [Abstract] [Full Text] [Related]

  • 6. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B, Tan X, Zhang Y, Li X, Wang X, Zhu J, Wang Y, Yang F, Wang B, Liu Y, Xu C, Pan Z, Wang N, Yang B, Lu Y.
    Stem Cells Transl Med; 2015 Dec 15; 4(12):1425-35. PubMed ID: 26586774
    [Abstract] [Full Text] [Related]

  • 7. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
    Le K, Li R, Xu S, Wu X, Huang H, Bao Y, Cai Y, Lan T, Moss J, Li C, Zou J, Shen X, Liu P.
    Arch Biochem Biophys; 2012 Feb 01; 518(1):71-8. PubMed ID: 22198280
    [Abstract] [Full Text] [Related]

  • 8. Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells.
    Qin Q, Chen M, Yi B, You X, Yang P, Sun J.
    J Mol Cell Cardiol; 2014 Dec 01; 77():20-8. PubMed ID: 25284689
    [Abstract] [Full Text] [Related]

  • 9. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
    Takaya T, Kawamura T, Morimoto T, Ono K, Kita T, Shimatsu A, Hasegawa K.
    J Biol Chem; 2008 Apr 11; 283(15):9828-35. PubMed ID: 18252717
    [Abstract] [Full Text] [Related]

  • 10. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.
    Li Y, Zhang H, Liao W, Song Y, Ma X, Chen C, Lu Z, Li Z, Zhang Y.
    Am J Physiol Heart Circ Physiol; 2011 Nov 11; 301(5):H1941-51. PubMed ID: 21856923
    [Abstract] [Full Text] [Related]

  • 11. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
    Wang T, Zhai M, Xu S, Ponnusamy M, Huang Y, Liu CY, Wang M, Shan C, Shan PP, Gao XQ, Wang K, Chen XZ, Liu J, Xie JY, Zhang DY, Zhou LY, Wang K.
    Theranostics; 2020 Nov 11; 10(2):553-566. PubMed ID: 31903137
    [Abstract] [Full Text] [Related]

  • 12. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X, Li J, Wang X, Chen N, Cai B, Wang G, Shan H, Dong D, Liu Y, Li X, Yang F, Li X, Zhang P, Li X, Yang B, Lu Y.
    Int J Biol Sci; 2011 Apr 07; 7(3):383-9. PubMed ID: 21494433
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Orphan nuclear receptor Nur77 affects cardiomyocyte calcium homeostasis and adverse cardiac remodelling.
    Medzikovic L, Schumacher CA, Verkerk AO, van Deel ED, Wolswinkel R, van der Made I, Bleeker N, Cakici D, van den Hoogenhof MM, Meggouh F, Creemers EE, Remme CA, Baartscheer A, de Winter RJ, de Vries CJ, Arkenbout EK, de Waard V.
    Sci Rep; 2015 Oct 21; 5():15404. PubMed ID: 26486271
    [Abstract] [Full Text] [Related]

  • 15. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
    Nunn C, Zou MX, Sobiesiak AJ, Roy AA, Kirshenbaum LA, Chidiac P.
    Cell Signal; 2010 Aug 21; 22(8):1231-9. PubMed ID: 20362664
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
    Suzuki H, Katanasaka Y, Sunagawa Y, Miyazaki Y, Funamoto M, Wada H, Hasegawa K, Morimoto T.
    Biochim Biophys Acta; 2016 Sep 21; 1862(9):1544-57. PubMed ID: 27208796
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.